BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen B. IBD: Step-up vs top-down therapy for Crohn's disease: medicine vs surgery. Nat Rev Gastroenterol Hepatol 2017;14:693-5. [PMID: 29018276 DOI: 10.1038/nrgastro.2017.139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Kuhn T, Koch M, Fuhrmann G. Probiomimetics—Novel Lactobacillus ‐Mimicking Microparticles Show Anti‐Inflammatory and Barrier‐Protecting Effects in Gastrointestinal Models. Small 2020;16:2003158. [DOI: 10.1002/smll.202003158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
2 Park J, Yoon H, Shin CM, Park YS, Kim N, Lee DH. Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease. PLoS One. 2020;15:e0233654. [PMID: 32502199 DOI: 10.1371/journal.pone.0233654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Breugelmans T, Van Spaendonk H, De Man JG, De Schepper HU, Jauregui-Amezaga A, Macken E, Lindén SK, Pintelon I, Timmermans JP, De Winter BY, Smet A. In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis. J Crohns Colitis 2020;14:974-94. [PMID: 32003421 DOI: 10.1093/ecco-jcc/jjaa015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
4 Hao X, Feng T, Yang Y, Shi Y, Jing R, Liu S, Luo Y, Qiao Y, Zhong M, Yu M. Laparoscopic bowel resection combined with infliximab treatment (LaRIC) versus infliximab for terminal ileitis in Crohn's disease: a randomised, controlled, open-label trial. BMJ Open 2020;10:e038429. [PMID: 33199421 DOI: 10.1136/bmjopen-2020-038429] [Reference Citation Analysis]
5 Ge X, Tang S, Yang X, Liu W, Ye L, Yu W, Xu H, Cao Q, Zhou W, Cai X. The role of exclusive enteral nutrition in the preoperative optimization of laparoscopic surgery for patients with Crohn's disease: A cohort study. Int J Surg 2019;65:39-44. [PMID: 30905758 DOI: 10.1016/j.ijsu.2019.03.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
6 Lin YS, Lin WC, Chen MJ, Wang YH, Chen C. Letter: when to withhold anti-TNF agents prior to abdominal surgery in patients with Crohn's disease-the jury might still be out. Authors' reply. Aliment Pharmacol Ther 2019;50:465-6. [PMID: 31359483 DOI: 10.1111/apt.15398] [Reference Citation Analysis]
7 Hong SW, Yoon H, Shin CM, Park YS, Kim N, Lee DH, Kim JS. Clinical significance of granulomas in Crohn's disease: A systematic review and meta-analysis. J Gastroenterol Hepatol 2020;35:364-73. [PMID: 31522456 DOI: 10.1111/jgh.14849] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
8 Ge X, Tang S, Qi W, Liu W, Lv J, Cao Q, Zhou W, Cai X. Prevalence and predictors of surgical site infections after bowel resection for Crohn's disease: the role of dual-ring wound protector. Int J Colorectal Dis 2019;34:879-87. [PMID: 30868209 DOI: 10.1007/s00384-019-03275-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Choi YI, Park SJ, Chung JW, Kim KO, Cho JH, Kim YJ, Lee KY, Kim KG, Park DK. Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study.J Clin Med. 2020;9:3427. [PMID: 33114505 DOI: 10.3390/jcm9113427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]